Riva-Posse P

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, United States.

3 papers · 1 preprint

ArticleKetamine

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.

Conway CR, Rush AJ, Aaronson ST +29

Europe PMC2026
PreprintKetamine

Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A RECOVER Trial Report

Conway CR, Rush AJ, Aaronson ST +29

Europe PMC2025
ArticleKetamine

Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.

Conway CR, Aaronson ST, Sackeim HA +23

Europe PMC2024
ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Loo C, Glozier N, Barton D +35

Europe PMC2023